EternoGen Aesthetics LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EternoGen Aesthetics LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10452
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EternoGen Aesthetics LLC (EA) a subsidiary of EternoGen LLC, is a clinical stage medical device company which develops and manufactures advanced collagen scaffolds to deliver bio dermal restoration in facial aesthetics. Its portfolio of collagen products include rapid polymerizing collagen (RPC) solution with EDTA and D-Mannitol is injected through a fine gauge needle or micro-cannula forms fibrous scaffold in contact with dermal or subcutaneous tissue gets converted to contour stable matrix which inhibits degradation and infill the scaffold forming natural tissue to support and reinforce the wrinkled skin; CG NanoMatrix harnesses collagen degradation, stimulate tissue regeneration and reduce inflammation formulated to extend duration to around two years. The company markets and distributes its products non-surgical medical aesthetic market. EA is headquartered in Columbia, Missouri, the US.

EternoGen Aesthetics LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EternoGen Aesthetics LLC, Medical Equipment, Deal Details 10
Venture Financing 10
EternoGen Aesthetics to Raise Funds through Venture Financing 10
EternoGen Aesthetics Raises USD5 Million in Venture Financing 11
EternoGen Aesthetics Raises Additional USD0.7 Million in Venture Financing 12
EternoGen Aesthetics Raises USD0.1 Million in Venture Financing 13
Dermelle Raises US$1 Million In Venture Financing 14
EternoGen Aesthetics LLC – Key Competitors 15
EternoGen Aesthetics LLC – Key Employees 16
EternoGen Aesthetics LLC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Jan 04, 2017: EternoGen opens offices at M2D2 18
Corporate Communications 19
Jan 04, 2017: EternoGen opens offices at M2D2 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
EternoGen Aesthetics LLC, Medical Equipment, Key Facts 2
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Deals By Market, 2012 to YTD 2018 8
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EternoGen Aesthetics to Raise Funds through Venture Financing 10
EternoGen Aesthetics Raises USD5 Million in Venture Financing 11
EternoGen Aesthetics Raises Additional USD0.7 Million in Venture Financing 12
EternoGen Aesthetics Raises USD0.1 Million in Venture Financing 13
Dermelle Raises US$1 Million In Venture Financing 14
EternoGen Aesthetics LLC, Key Competitors 15
EternoGen Aesthetics LLC, Key Employees 16
EternoGen Aesthetics LLC, Other Locations 17

List of Figures
EternoGen Aesthetics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[EternoGen Aesthetics LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Bank of Okinawa, Ltd. (8397):企業の財務・戦略的SWOT分析
    The Bank of Okinawa, Ltd. (8397) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hanmi Pharmaceuticals Co Ltd (128940):企業の財務・戦略的SWOT分析
    Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Porto Seguro SA:企業の戦略・SWOT・財務情報
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Amsted Industries Inc:企業の戦略・SWOT・財務情報
    Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • V. F. Corporation:企業の戦略・SWOT・財務情報
    V. F. Corporation - Strategy, SWOT and Corporate Finance Report Summary V. F. Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vyome Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a research center that develops drugs for antibiotics-resistant acne and other opportunist pathogens. The center’s platforms modify active agents based on genomic information of the disease causing micro organism. Its pro-drug platform develops therapeuti …
  • Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its p …
  • Paul Hastings LLP:企業の戦略的SWOT分析
    Paul Hastings LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Freehold Royalties Ltd (FRU):企業の財務・戦略的SWOT分析
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. Its oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provides horizon …
  • Reliance General Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Reliance General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Innovative Targeting Solutions Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovative Targeting Solutions Inc (ITS) is an antibody generation company that discovers and develops novel human monoclonal antibody technologies. The company develops a next generation protein engineering platform that helps for the generation of fully human antibody and T cell receptor b …
  • Genome Institute of Singapore:医療機器:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Ophir Energy Plc (OPHR):石油・ガス:M&Aディール及び事業提携情報
    Summary Ophir Energy Plc (Ophir) is an independent upstream oil and gas company, which explores for and develops oil and gas properties. The company has working interests in assets across Africa and Asia. Ophir has assets in Tanzania, Equatorial Guinea, Kenya, Cote d’Ivoire, and Gabon in Africa; and …
  • Satrec Initiative Co., Ltd.:企業の戦略・SWOT・財務情報
    Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fulgent Genetics Inc (FLGT):企業の財務・戦略的SWOT分析
    Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oxford BioMedica Plc (OXB):企業の財務・戦略的SWOT分析
    Oxford BioMedica Plc (OXB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Impresa Pizzarotti & C. S.p.A.:企業の戦略・SWOT・財務情報
    Impresa Pizzarotti & C. S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Impresa Pizzarotti & C. S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CeraPedics Inc-医療機器分野:企業M&A・提携分析
    Summary CeraPedics Inc (Cerapedics) is a provider of osteobiologic treatment solutions. The company’s products include i-factor putty and i-factor flex. Its i-factor putty is a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to …
  • Innergex Renewable Energy Inc (INE):電力:M&Aディール及び事業提携情報
    Summary Innergex Renewable Energy Inc (Innergex) is an independent renewable power producer. It develops, acquires, owns and operates hydroelectric facilities, wind farms, and solar photovoltaic geothermal power facilities. Through long-term power purchase agreements, the company sells electricity t …
  • Anhui Water Resources Development Co Ltd (600502):企業の財務・戦略的SWOT分析
    Summary Anhui Water Resources Development Co Ltd (Anhui Water) is an investment holding company. The company operates in the business of construction, real estate development, and hydropower investment construction and operation. It operates as a general contractor of water conservancy projects, hou …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆